JPS62221629A - Production of phospholipid emulsion - Google Patents
Production of phospholipid emulsionInfo
- Publication number
- JPS62221629A JPS62221629A JP61063335A JP6333586A JPS62221629A JP S62221629 A JPS62221629 A JP S62221629A JP 61063335 A JP61063335 A JP 61063335A JP 6333586 A JP6333586 A JP 6333586A JP S62221629 A JPS62221629 A JP S62221629A
- Authority
- JP
- Japan
- Prior art keywords
- emulsion
- oil
- phospholipid
- viscosity
- dispersion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000839 emulsion Substances 0.000 title claims abstract description 92
- 150000003904 phospholipids Chemical class 0.000 title claims abstract description 57
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 239000006185 dispersion Substances 0.000 claims abstract description 25
- 230000007935 neutral effect Effects 0.000 claims abstract description 23
- 150000002632 lipids Chemical class 0.000 claims abstract description 22
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 22
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000787 lecithin Substances 0.000 claims abstract description 16
- 235000010445 lecithin Nutrition 0.000 claims abstract description 16
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 12
- 229940067606 lecithin Drugs 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 102000009027 Albumins Human genes 0.000 claims abstract description 6
- 108010088751 Albumins Proteins 0.000 claims abstract description 6
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims abstract description 4
- 235000018102 proteins Nutrition 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 9
- -1 casein sodium salt Chemical class 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000005018 casein Substances 0.000 claims description 4
- 235000021240 caseins Nutrition 0.000 claims description 4
- 238000000265 homogenisation Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000003921 oil Substances 0.000 abstract description 29
- 235000019198 oils Nutrition 0.000 abstract description 29
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 10
- 235000012424 soybean oil Nutrition 0.000 abstract description 7
- 239000003549 soybean oil Substances 0.000 abstract description 7
- 102000011632 Caseins Human genes 0.000 abstract description 5
- 108010076119 Caseins Proteins 0.000 abstract description 5
- 235000019484 Rapeseed oil Nutrition 0.000 abstract description 2
- 229940080237 sodium caseinate Drugs 0.000 abstract description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- 239000012530 fluid Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 20
- 238000003756 stirring Methods 0.000 description 16
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 11
- 230000001804 emulsifying effect Effects 0.000 description 11
- 239000003925 fat Substances 0.000 description 11
- 235000019197 fats Nutrition 0.000 description 11
- 238000000926 separation method Methods 0.000 description 10
- 229940083466 soybean lecithin Drugs 0.000 description 10
- 239000007787 solid Substances 0.000 description 8
- 238000004945 emulsification Methods 0.000 description 7
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000007423 decrease Effects 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 229940042880 natural phospholipid Drugs 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 235000005713 safflower oil Nutrition 0.000 description 3
- 239000003813 safflower oil Substances 0.000 description 3
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229940071162 caseinate Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000014103 egg white Nutrition 0.000 description 2
- 210000000969 egg white Anatomy 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 235000013345 egg yolk Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 235000008853 Zanthoxylum piperitum Nutrition 0.000 description 1
- 244000131415 Zanthoxylum piperitum Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000002612 dispersion medium Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000008344 egg yolk phospholipid Substances 0.000 description 1
- 229940068998 egg yolk phospholipid Drugs 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 125000003473 lipid group Chemical group 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、ホスファチジルコリン(以下PCという)を
含有するリン脂質を生体に摂取しやすくするために、流
動性よく低粘度に均質化させる新しいリン脂質乳剤の製
造方法に関するものである。[Detailed Description of the Invention] [Field of Industrial Application] The present invention is directed to a new phospholipid homogenized with good fluidity and low viscosity in order to make it easier for living organisms to ingest phospholipids containing phosphatidylcholine (hereinafter referred to as PC). The present invention relates to a method for producing a lipid emulsion.
食品や医薬品に使用されている大豆レシチンや卵黄レシ
チンなどの天然レシチンは、それに含まれる各種リン脂
質の構造中に疎水基と親木基が併存することから、界面
活性があることが古くから知られており、この性質を利
用して各種工業分野で乳化剤として使用されている。工
業用乳化剤として使用される天然レシチンは、通常リン
脂質組成物と油脂の混合状態で使用され、弱いW/○型
および○/W型の乳化性をもっており、この乳化性を用
いて、マーガリン、インスタントココアドリンク等の食
品加工、蚊の駆除剤等の薬剤加工および皮革加工などの
広い範囲で応用されている。It has long been known that natural lecithins, such as soybean lecithin and egg yolk lecithin, used in foods and medicines have surface activity due to the coexistence of hydrophobic groups and parent wood groups in the structure of the various phospholipids they contain. Utilizing this property, it is used as an emulsifier in various industrial fields. Natural lecithin, which is used as an industrial emulsifier, is usually used as a mixture of phospholipid compositions and fats and oils, and has weak W/○ type and ○/W type emulsifying properties.Using this emulsifying property, margarine, It is widely used in food processing such as instant cocoa drinks, pharmaceutical processing such as mosquito repellents, and leather processing.
一方PCの薬理効果および食品としての価値に注目して
、PCを含有するリン脂質を摂取するために、リン脂質
の油脂中溶解物のカプセル品を食べる方法がある。この
方法ではlogのPCを摂取するためには、1000m
gカプセルに充填しても、卵黄油では40〜50個、大
豆レシチンでは100個程度を服用する点で実用的でな
い、また卵黄油から中性脂質を除去した卵黄リン脂質は
高度不飽和脂肪酸が含まれているため冷凍、遮光が必要
であり、直接摂取が難しい、同様に大豆レシチンから中
性脂質を除去した大豆リン脂質は保存安定性および剤形
加工性が良好である反面、PCの含有量が22〜24%
と低く 、 PC10gの摂取に大豆リン脂質50g程
度の顆粒および錠剤を食べる必要があり、その容積は非
常に大量であり幌上が困難である。On the other hand, focusing on the pharmacological effects and value of PC as a food, there is a method of ingesting phospholipids containing PC by eating capsules of phospholipids dissolved in fats and oils. In this method, in order to ingest log PC, 1000m
Even if it is filled into capsules, it is not practical because you will need to take 40 to 50 pieces of egg yolk oil and about 100 pieces of soybean lecithin.Also, egg yolk phospholipids, which are obtained by removing neutral lipids from egg yolk oil, contain highly unsaturated fatty acids. Soybean phospholipids, which are obtained by removing neutral lipids from soybean lecithin, have good storage stability and ease of processing into dosage form, but they contain PC. The amount is 22-24%
To consume 10g of PC, it is necessary to eat about 50g of soybean phospholipid granules and tablets, which is extremely large and difficult to carry.
PCの薬理効果および食品としての価値に着目して、P
Cを医薬品または食品として摂取するために、上記のよ
うなリン脂質の剤型では摂取が困難であり、その剤型の
変更が望ましい。このような新しい剤型としてリン脂質
乳剤が好ましいが、天然レシチンは水に対する分散性が
なく、乳剤とすることは困難である。前述のように天然
レシチンは乳化剤として使用されているが、これは主剤
である大量の油脂を少量のレシチンで乳化する場合に限
られ、大量の天然レシチンを水に均一に分散させて、こ
れを安定な乳剤とすることは困難である。Focusing on the pharmacological effects of PC and its value as a food, P.
In order to ingest C as a medicine or food, it is difficult to take it in the above-mentioned phospholipid dosage form, and it is desirable to change the dosage form. Phospholipid emulsions are preferred as such new dosage forms, but natural lecithin has no dispersibility in water and is difficult to form into emulsions. As mentioned above, natural lecithin is used as an emulsifier, but this is limited to emulsifying a large amount of oil, which is the main ingredient, with a small amount of lecithin. It is difficult to form a stable emulsion.
本発明は上記問題点を解決するためのもので、低粘度で
流動性よく、かつ安定に均質化され、摂取が容易な高濃
度のリン脂質乳剤の製造方法を桿供することを目的とし
ている。The present invention is intended to solve the above problems, and aims to provide a method for producing a high-concentration phospholipid emulsion that has low viscosity, good fluidity, is stably homogenized, and is easy to ingest.
本発明は、天然レシチンから中性脂質を除去してホスフ
ァチジルコリンを20重景%以上含む精製リン脂質を得
、この精製リン脂質の10〜50重量%水性分散液に、
前記精製リン脂質に対して20〜100重量%の油脂お
よび0.1〜40重量%の蛋白質を添加混合し、均質化
することを特徴とするリン脂質乳剤の製造方法である。The present invention removes neutral lipids from natural lecithin to obtain purified phospholipids containing 20 weight percent or more of phosphatidylcholine, and adds 10 to 50 weight percent aqueous dispersion of this purified phospholipid to
This is a method for producing a phospholipid emulsion, which comprises adding and mixing 20 to 100% by weight of oil and fat and 0.1 to 40% by weight of protein to the purified phospholipid and homogenizing the mixture.
天然リン脂質の水に対する分散性が悪い原因を調べたと
ころ、天然リン脂質はPCが中性脂質中に溶解した状態
となっており、pcは中性脂質に被覆されているため、
中性脂質撥水作用により水に対する分散性が悪くなるも
のと推定された。When we investigated the cause of the poor dispersibility of natural phospholipids in water, we found that in natural phospholipids, PC is dissolved in neutral lipids, and PC is coated with neutral lipids.
It was presumed that the water repellency of the neutral lipid deteriorated its dispersibility in water.
このため本発明では分散性を阻害する天然レシチン中の
中性脂質を除去してPC濃度の高い精製リン脂質とし、
これを大量に水に分散させて水性分散液とする。この水
性分散液はリン脂質含量が低いときは低粘度であるが、
高いときは高粘度となり、乳剤として不適である。とこ
ろがこの水性分散液に油脂を加えることにより低粘度の
分散液が得られる。しかしながらこの分散液は乳化安定
性が悪く、安定な乳剤が得られないが、これに少量の蛋
白質を加えて乳化することにより安定な乳剤が得られ、
高濃度域における粘度はさらに低下する。Therefore, in the present invention, neutral lipids in natural lecithin that inhibit dispersibility are removed to produce purified phospholipids with high PC concentration,
This is dispersed in a large amount of water to form an aqueous dispersion. This aqueous dispersion has a low viscosity when the phospholipid content is low;
When it is high, the viscosity becomes high, making it unsuitable as an emulsion. However, by adding oil or fat to this aqueous dispersion, a low-viscosity dispersion can be obtained. However, this dispersion has poor emulsion stability and cannot produce a stable emulsion; however, by adding a small amount of protein to it and emulsifying it, a stable emulsion can be obtained.
The viscosity in the high concentration range further decreases.
本発明で使用する天然レシチンは大豆レシチン、卵黄レ
シチンなどがある。これらの天然レシチンはPC含量が
15〜16重量%で、大部分は中性脂質である。本発明
ではこのような天然リン脂質中の中性脂質を除去してP
C含量20重量%以上、好ましくは50重量%以上、さ
らに好ましぐは7o重量%以上の精製リン脂質とする。Natural lecithins used in the present invention include soybean lecithin and egg yolk lecithin. These natural lecithins have a PC content of 15-16% by weight and are mostly neutral lipids. In the present invention, neutral lipids in such natural phospholipids are removed and P
The purified phospholipid has a C content of 20% by weight or more, preferably 50% by weight or more, and more preferably 70% by weight or more.
PC含量はイヤストロスキャン法によって測定される。PC content is measured by the Iastroscan method.
天然レシチンの中性脂質を除去する方法としては、冷ア
セトン処理、含水エタノール処理などの公知の方法が採
用でき、1回の処理で目標とするPC含量に達しないと
きは同じ操作を繰返えし、あるいは他の操作と組合せて
行うことができる。Known methods such as cold acetone treatment and aqueous ethanol treatment can be used to remove neutral lipids from natural lecithin, and if the target PC content is not reached in one treatment, the same operation can be repeated. or in combination with other operations.
こうして得られた精製リン脂質は乳化装置を用いて水に
分散させ、固形分がなくなり完全に糊状になるように攪
拌して予備乳化を行い、精製リン脂質10〜50重量%
の水性分散液とする。このとき分散媒として80℃以上
の熱水を使用するのが好ましく、これにより後に添加す
る油脂および蛋白質を可溶化することができる。水性分
散液中の精製リン脂質濃度が10重量%未満では、最終
の乳剤の有効成分が低くなり、50重量%を越えると乳
化液の粘度が上り乳化が不良となるので好ましくない。The purified phospholipids thus obtained are dispersed in water using an emulsifying device, stirred until the solid content is completely eliminated, and pre-emulsified.
An aqueous dispersion of At this time, it is preferable to use hot water of 80° C. or higher as a dispersion medium, thereby making it possible to solubilize the fats and oils and proteins added later. If the purified phospholipid concentration in the aqueous dispersion is less than 10% by weight, the final emulsion will have a low active ingredient content, and if it exceeds 50% by weight, the viscosity of the emulsion will increase, resulting in poor emulsification, which is not preferred.
次に、この予備乳化を行った水性分散液に80℃以上の
温度にて、同じ<80℃以上に加温した油脂を少量ずつ
加えて分散し、精乳化して乳化液とする。この処理を行
うことにより、同一精製リン脂質濃度の予備乳化液に比
べて粘度が低下し、流動性を改善することができる。Next, at a temperature of 80° C. or higher, fats and oils heated to the same <80° C. or higher are added little by little to the pre-emulsified aqueous dispersion, dispersed, and refined to form an emulsion. By performing this treatment, the viscosity can be lowered compared to a pre-emulsified liquid having the same purified phospholipid concentration, and the fluidity can be improved.
添加する油脂は、常温で液体である大豆油、菜種油、綿
実油、唐蜀黍油、紅花油等が好ましく、添加量は精製リ
ン脂質に対し20〜100重量%であり、好ましくは5
0〜100重量%である。油1旧量が20重量%未満で
は粘度低下効果が少なく、100重量%を越えると相対
的にPC量が減り好ましくない。The fats and oils to be added are preferably soybean oil, rapeseed oil, cottonseed oil, chili pepper oil, safflower oil, etc., which are liquid at room temperature, and the amount added is 20 to 100% by weight based on the purified phospholipid, preferably 5% by weight.
It is 0 to 100% by weight. If the amount of oil 1 is less than 20% by weight, the viscosity lowering effect will be small, and if it exceeds 100% by weight, the PC amount will be relatively reduced, which is not preferable.
続いてこの乳化液に、80℃以上に加温攪拌しながら蛋
白質を少量ずつ加えて完全に溶解するまで分散し、さら
に高圧分散機にて精乳化し乳剤とする。この処理を行う
ことによって乳化は安定し。Next, the protein is added little by little to this emulsion while stirring while heating to 80° C. or higher, and the protein is dispersed until it is completely dissolved.The protein is further emulsified using a high-pressure dispersion machine to form an emulsion. This treatment stabilizes the emulsion.
油層の分離を防ぐとともに高濃度域における粘度をさら
に低下させることができる。It is possible to prevent separation of the oil layer and further reduce the viscosity in the high concentration range.
添加する蛋白質は、カゼイン、カゼインナトリウム塩、
アルブミン、卵白、脱脂粉乳等であって、添加量は精製
リン脂質に対して0.1〜40重量%であり、好ましく
は0.5〜IO重量%である。添加量が0.1重社%未
満では乳化安定の効果がなく、40重量%を越えると、
乳剤のpc含量が減じ粘度が上昇する。The proteins to be added include casein, casein sodium salt,
Albumin, egg white, skim milk powder, etc. are added in an amount of 0.1 to 40% by weight, preferably 0.5 to IO% by weight, based on the purified phospholipid. If the amount added is less than 0.1% by weight, there is no emulsion stabilizing effect, and if it exceeds 40% by weight,
The PC content of the emulsion decreases and the viscosity increases.
高圧分散機による均質化は、ホモゲナイザー等の分散機
を用いて20〜200kg/Cdの高圧下で行われるが
、第1段は50kg/cd、第2段は150kg/a+
ta度の高圧下で分散を行うのが良い。Homogenization using a high-pressure dispersion machine is carried out under high pressure of 20 to 200 kg/cd using a dispersion machine such as a homogenizer, with the first stage being 50 kg/cd and the second stage being 150 kg/a+.
It is preferable to carry out the dispersion under a high pressure of 100 degrees.
以下本発明の製造方法を、実験結果に基づいてさらに詳
細に説明する。The manufacturing method of the present invention will be explained in more detail below based on experimental results.
脂肪乳剤用の乳化剤として利用されている中性脂質を混
在する大豆レシチンや卵黄レシチン等の天然レシチンは
、そのままでは予備乳化のための機械的攪拌後でも、水
層上部にリン脂質が凝集している。この状態はコーヒー
に加えられたホワイトナーが起こすフェザーリング現象
に酷似し、全く均一な懸濁液は得られず、油層分離が明
確である。この現象はリン脂質を可溶化している溶媒で
ある油脂などの中性脂質群の撥水性により、リン脂質が
水と接触できないために起きたと推定される。Natural lecithins such as soybean lecithin and egg yolk lecithin, which are used as emulsifiers for fat emulsions and contain neutral lipids, can cause phospholipids to aggregate in the upper part of the water layer even after mechanical stirring for preliminary emulsification. There is. This condition is very similar to the feathering phenomenon caused by whitener added to coffee; a completely uniform suspension is not obtained, and oil layer separation is clear. This phenomenon is presumed to have occurred because the phospholipids cannot come into contact with water due to the water repellency of the neutral lipid group such as oil, which is the solvent that solubilizes the phospholipids.
このような天然リン脂質に冷アセトン処理、含水エタノ
ール処理等を加えて中性脂質を除去するとpc含量の高
い精製リン脂質が得られる。例えば大豆レシチンから中
性脂質を除去したpc含量70%(重量%−以下間)の
精製リン脂質(以下、5−PC−70という)は黄色透
明で、非常に可塑性に富んだ固体であり、その可塑性は
冷却や加温によって著しく変化せず、味は温和であるが
、その可塑性のため歯で咀嗟することが難しく、歯や上
顎に粘着して粘土を食べるような感じであり服用は難し
い。When such natural phospholipids are subjected to cold acetone treatment, hydrous ethanol treatment, etc. to remove neutral lipids, purified phospholipids with a high PC content can be obtained. For example, purified phospholipid (hereinafter referred to as 5-PC-70) with a PC content of 70% (weight% or less) obtained by removing neutral lipids from soybean lecithin is a transparent yellow solid with extremely high plasticity. Its plasticity does not change significantly with cooling or heating, and its taste is mild, but its plasticity makes it difficult to chew with the teeth, and it sticks to the teeth and upper jaw, making it feel like eating clay. difficult.
また同様に卵黄レシチンから中性脂質を除去したpc含
量70%の精製リン脂質(以下E −PC−70という
)も、褐色半透明で、油っぽい触感のする柔らかくて非
常に可塑性に富んだ半固体であり、その可塑性も冷却や
加温によって著しく変化せず、味は非常に油っぽく、口
腔全体が長時間にわたってオイルコーティングされてい
る感触が残り、大豆品と同様に咀噌しにくい点や粘着す
る点から長期服用は麗しい。Similarly, purified phospholipid with a PC content of 70% (hereinafter referred to as E-PC-70), which is obtained by removing neutral lipids from egg yolk lecithin, is brown and translucent, has an oily texture, is soft, and is highly plastic. It is a semi-solid, its plasticity does not change significantly when cooled or heated, it has a very oily taste, the whole mouth remains coated in oil for a long time, and it is difficult to chew, similar to soybean products. It is beautiful to take for a long time because of its dots and stickiness.
上記S −PC−70、E −PC−70および大豆レ
シチンから中性脂質を除去したpc含量24%の精製リ
ン脂質(以下、 S −PC−24という)について予
備乳化実験を行った結果では、いずれの試料についても
、10%(vt/wt)までの均一な水性分散液が得ら
れるが、10%以上の水性分散液では後述の第1表に示
すように著しく粘度が上昇する。粘度上昇の傾向はpc
含量の低いS −PC−24の場合は、pc含量の高い
5−pc−70やE −PC−70より高濃度側に移行
する。According to the results of a preliminary emulsification experiment on the above S-PC-70, E-PC-70, and purified phospholipid with a PC content of 24% (hereinafter referred to as S-PC-24) obtained by removing neutral lipids from soybean lecithin, For all samples, uniform aqueous dispersions up to 10% (vt/wt) were obtained, but aqueous dispersions of 10% or more significantly increased viscosity as shown in Table 1 below. The tendency of viscosity increase is pc
In the case of S-PC-24, which has a low PC content, it shifts to a higher concentration side than 5-PC-70 and E-PC-70, which have a high PC content.
pc含量の高い精製リン脂質を10%以上含有し、しか
も安定性および流動性の優れた乳剤を調製するためには
、水に均等に懸濁しているリン脂In溶液に常温で液体
のトリアジルグリセロール(本実験では大豆油使用)を
添加して精乳化することによって可能であり、後述の第
3表に示すようにpc含量70%のものが10%溶液に
おいて粘度低下が生じ、流動性が改善される。In order to prepare an emulsion containing 10% or more of purified phospholipids with a high PC content and excellent stability and fluidity, it is necessary to add triazyl, which is liquid at room temperature, to a phospholipid In solution that is evenly suspended in water. This is possible by adding glycerol (soybean oil was used in this experiment) and emulsifying it, and as shown in Table 3 below, the viscosity of a 70% PC solution decreases in a 10% solution, and the fluidity decreases. Improved.
さらに高′a度域での粘度低下および安定性の向上をは
かるためには、上記の乳化液に蛋白質を加えてトリアジ
ルグリセロールとリン脂質の粒子をコーティングするこ
とにより、これらの改善が可能である。これらの一連の
現象は、中性脂質を核としてその周囲をリン脂質が局在
し、さらに水中での油滴の安定性を維持するために、蛋
白質がコーティングしている血液中の脂質運搬体である
リポ蛋白の構造に類似しているものと推測される。Furthermore, in order to reduce the viscosity and improve the stability in the high a degree range, these improvements can be made by adding protein to the above emulsion and coating it with triazylglycerol and phospholipid particles. be. These series of phenomena are caused by the localization of phospholipids around a neutral lipid core, and lipid carriers in the blood that are coated with proteins to maintain the stability of oil droplets in water. It is assumed that the structure is similar to that of lipoproteins.
トリアジルグリセロール添加リン脂質乳剤は。Triazylglycerol added phospholipid emulsion.
精乳化を行っても1週間程度で保存サンプルの上層に油
層分離が認められるが、さらに蛋白質を加えることによ
り油滴の安定性維持が可能である。Even if emulsification is performed, oil layer separation is observed in the upper layer of the stored sample after about a week, but it is possible to maintain the stability of the oil droplets by adding protein.
蛋白質含有乳剤の調製はトリアジルグリセロール添加リ
ン脂質の予備乳化液に蛋白質を添加し、加温攪拌状態で
十分可溶化してからホモゲナイザーで精乳化する。この
乳化液の乳化安定性を[1すると、1力月保存しても油
層分離は認められない。To prepare a protein-containing emulsion, protein is added to a pre-emulsion of phospholipid added with triazylglycerol, sufficiently solubilized by heating and stirring, and then refined and emulsified using a homogenizer. If the emulsion stability of this emulsion is 1, no oil layer separation will be observed even after storage for 1 month.
リン脂質、トリアジルグリセロールおよびカゼインナト
リウム塩の3成分系における代表的な乳化液の粘度は後
述の第1表に示す通りであり、このように蛋白質添加に
よる精乳化液の粘度は、第2表と比較しても明らかなよ
うにPCが10%以上の溶液で顕著に低下する。The viscosity of a typical emulsion in a three-component system of phospholipids, triadylglycerol, and sodium casein salt is shown in Table 1 below, and the viscosity of a refined emulsion with protein addition is shown in Table 2. As is clear from the comparison, PC decreases significantly in solutions with a concentration of 10% or more.
これらの乳化系には特徴的な粘度挙動が810される。These emulsion systems exhibit characteristic viscosity behavior 810.
すなわちS −PC−70単独の懸濁液は第2表に示し
たように、その含量が5%、10%、15%と多くなる
と、その系の80℃における粘度は27.380゜70
00cPであるが、15℃においては70.2700゜
40000cPと増粘する。しかし、トリアジルグリセ
ロールを添加した乳化系では、第3表に示すように、8
0℃で5 、17.2500cPである粘度が、15℃
では8 、27.4700cPと増粘傾向が少ない。こ
れは水相に対する分散状態が水和からエマルジョンに変
化したためと推定される。That is, as shown in Table 2, a suspension of S-PC-70 alone has a viscosity of 27.380°70 at 80°C when its content increases to 5%, 10%, and 15%.
00cP, but at 15°C, the viscosity increases to 70.2700°40000cP. However, in the emulsion system containing triazylglycerol, as shown in Table 3, 8
The viscosity is 5,17.2500 cP at 0°C, but at 15°C
8, 27.4700 cP, with little tendency to increase viscosity. This is presumed to be because the state of dispersion in the aqueous phase changed from hydration to emulsion.
またカゼインナトリウム塩を添加した乳化系では、第1
表に示したように、リン脂質の含量が5%、10%、
15%と多くなると、その系の80℃における粘度は、
4.38. 80cPY、、’>る、腸■■■園I−以
上のことは、他のリン脂質、中性脂質、および蛋白質に
よる乳化系1例えば中性脂質をコレステロールに変更し
たり、蛋白質を血漿中で遊離脂肪酸と特異的に結合する
アルブミンを卵白から供給しても同様である。In addition, in the emulsion system containing sodium caseinate, the first
As shown in the table, the phospholipid content is 5%, 10%,
When the amount increases to 15%, the viscosity of the system at 80°C is
4.38. 80 cPY,,'>ru, intestine ■■■ Garden I-The above is based on emulsification system using other phospholipids, neutral lipids, and proteins. The same is true when albumin, which specifically binds free fatty acids, is supplied from egg white.
以上によって得られるリン脂質含量が高い乳剤は、輸液
療法に広く応用できる。特にpc含量の高いリン脂質乳
剤は、PCの経口摂取に適した形態であり、固形PCよ
りも食べやすく、大量摂取しやすい。また1日20gの
PC摂取でも500cal程度のエネルギー摂取で済む
という利点がある。The emulsion with a high phospholipid content obtained as described above can be widely applied to infusion therapy. In particular, a phospholipid emulsion with a high PC content is a form suitable for oral ingestion of PC, and is easier to eat and ingest in large quantities than solid PC. Another advantage is that even if you take in 20g of PC per day, you only need to take in about 500cal of energy.
大豆レシチンや卵黄レシチンは脂肪乳剤、特にインドラ
リピッドやマイクロスフェア−の乳化剤に使用されてい
るように、生体適合性が良い物質で毒性は低い1例えば
E −PC−70やS −PC−70は経ロチL D
g oが12000mg/kg以上、静脈注射テLD!
。が2000mg/kg以上であり、トリアジルグリセ
ロール添加の場合、調製後短期間であれば経口および末
梢静脈からのPC74給が可能である。リン脂質とトリ
アジルグリセロールで予備乳化し、さらに蛋白質を添加
して調製した乳剤は経口、経腸などの経管による投与も
可能である。この系に使用する蛋白質にヒト血漿アルブ
ミン等の非抗原性の物質を使用すれば、静脈注射も可能
となる。Soybean lecithin and egg yolk lecithin are substances with good biocompatibility and low toxicity, as they are used in fat emulsions, especially indoralipid and microsphere emulsifiers.For example, E-PC-70 and S-PC-70 are Sutra Lochi LD
Go is 12000mg/kg or more, intravenous injection LD!
. If the amount is 2000 mg/kg or more and triazylglycerol is added, PC74 can be administered orally or via peripheral veins for a short period of time after preparation. Emulsions prepared by pre-emulsifying with phospholipids and triazylglycerol and further adding proteins can also be administered orally, enterally or through other tubes. If a non-antigenic substance such as human plasma albumin is used as the protein used in this system, intravenous injection becomes possible.
以上の通り、本発明によれば、天然レシチンの中性脂質
を除去して水溶分散液とし、これに油脂および蛋白質を
添加して乳化するようにしたので、低粘度で流動性よく
、かつ安定に均質化され、摂取が容易で安全な高濃度の
リン脂質乳剤を容易に製造することができる。As described above, according to the present invention, the neutral lipids of natural lecithin are removed to form an aqueous dispersion, and oil and fat and protein are added to this to emulsify it, resulting in low viscosity, good fluidity, and stability. It is possible to easily produce a highly concentrated phospholipid emulsion that is homogenized and safe to ingest.
以下、実施例および比較例によって本発明をさらに詳述
する。各例中、51部はそれぞれ重量%、重量部を示す
。また精製リン脂質は次のようにして製造した。Hereinafter, the present invention will be explained in further detail with reference to Examples and Comparative Examples. In each example, 51 parts indicate weight % and parts by weight, respectively. Further, purified phospholipids were produced as follows.
■ 中性脂肪を除いた大豆レシチンを、含水エタノール
で処理してPC含量70%の5−PC−70を得た。(2) Soybean lecithin from which neutral fats were removed was treated with aqueous ethanol to obtain 5-PC-70 with a PC content of 70%.
■ 大豆レシチンを冷アセトン処理を繰返し。■ Repeated cold acetone treatment of soybean lecithin.
PC含量24%のS −PC−24を得た。S-PC-24 with a PC content of 24% was obtained.
■ 卵黄レシチンを冷アセトン処理を繰返し、pc含量
70%のE −PC−70を得た。(2) Egg yolk lecithin was repeatedly treated with cold acetone to obtain E-PC-70 with a PC content of 70%.
実施例l
5−PC−70とIE−PC−70を用い、オートホモ
ミキサー(特殊機化工業製)を乳化装置とし5回転数1
1000Orp、温度80℃で30分間の機械的乳化を
行い、リン脂質含量5%、7.5%、10%、15%、
20%、25%の水性予備乳化液を調製し、この水性予
備乳化液に、水性予備乳化液中のリン脂質100部に対
し、80℃に加温した100部の大豆油を加え、オート
ホモミキサーを用いて精乳化しそれぞれの乳化液を得た
。この乳化液に、乳化液中のリン脂質100部に対し4
0部のカゼインナトリウム塩を加え、ホモゲナイザー(
三相特殊機械製MM型)を用いて精乳化し乳剤を得た。Example 1 Using 5-PC-70 and IE-PC-70, an autohomo mixer (manufactured by Tokushu Kika Kogyo) was used as the emulsifying device, and the number of revolutions was 1.
Mechanical emulsification was performed for 30 minutes at 1000 Orp and a temperature of 80°C, and the phospholipid content was 5%, 7.5%, 10%, 15%,
20% and 25% aqueous pre-emulsions were prepared, and 100 parts of soybean oil heated to 80°C was added to the aqueous pre-emulsions based on 100 parts of phospholipids in the aqueous pre-emulsions, and autohomogenized. The mixture was emulsified using a mixer to obtain each emulsion. Add 4 parts to this emulsion per 100 parts of phospholipid in the emulsion.
Add 0 parts of casein sodium salt and use a homogenizer (
An emulsion was obtained by emulsifying the emulsion using a MM type manufactured by Sansho Tokushu Kikai Co., Ltd.).
得られた乳剤の粘度を第1表に示す。Table 1 shows the viscosity of the emulsion obtained.
第 1 表 粘度(cP)
第1表の結果から、リン脂質含量が25%である乳剤は
、成分濃度が60%になるにもがかわらず。Table 1 Viscosity (cP)
From the results in Table 1, it can be seen that the emulsion with a phospholipid content of 25% has a component concentration of 60%.
80℃の粘度が低く、安定性も優れ、37℃で1ケ月間
放置後でも油層分離は認められなかった。The viscosity at 80°C was low and the stability was excellent, and no oil layer separation was observed even after being left at 37°C for one month.
実施例2
20Qのステンレスビーカーに80℃以上の熱水950
0部を計量し、スリーワンモーターで回転数240rp
IIで攪拌しながら細かく剪断した5−PC−70(前
出)の5000部を少量ずつ添加し、全体が均一の糊状
態となり固形分がなくなるまで続けた。Example 2 Hot water of 80℃ or higher 950℃ in a 20Q stainless steel beaker
Weigh 0 parts and rotate at 240 rpm with a three-one motor.
While stirring with II, 5000 parts of finely sheared 5-PC-70 (described above) was added little by little until the entire mixture became a uniform paste and no solid content was present.
糊状の予備乳化液に80℃以上に加熱した精製大豆油5
000部を少量ずつ添加し、攪拌速度を最高速にして半
透明溶液から乳白色溶液となるまで攪拌を続行した。こ
の乳化液にカゼインナトリウム塩50部を少量ずつ添加
し、完全に溶解するまで攪拌した。この乳化液を二段式
ホモゲナイザ−(三相特殊機械IIMM型)で、1段目
50kg/cd、2段目150kg/cdで精乳化した
後、オートクレーブに入れ温度110℃、圧力2kg/
aJで30分滅菌し乳剤を得た。Refined soybean oil heated to 80℃ or higher in a paste-like preliminary emulsion 5
000 parts were added little by little, stirring was continued at the highest stirring speed until the solution changed from a translucent solution to a milky white solution. 50 parts of caseinate sodium salt was added little by little to this emulsion and stirred until completely dissolved. This emulsion was emulsified using a two-stage homogenizer (three-phase special machine IIMM type) at a rate of 50 kg/cd in the first stage and 150 kg/cd in the second stage, and then placed in an autoclave at a temperature of 110°C and a pressure of 2 kg/cd.
It was sterilized for 30 minutes with aJ to obtain an emulsion.
滅菌乳剤を15℃付近まで急冷し、−昼夜冷蔵庫に保存
後、滅菌窒素置換の共栓フラスコに入れ37℃の恒温槽
に保存した。この乳剤は水に完全分散し、エマルジョン
の粒子径は3〜10μmであった。B型回転粘度計(東
京計器製造所!I)で測定した粘度は80℃で220c
P、37℃で380cP、15℃で730cPであった
。恒温槽中で1力月後の乳剤は腐敗や油層分離は認めら
れなかったが、37℃における粘度が640cPに上昇
した。1力月後の乳剤の経口摂取は多少粘性を感じる程
度で、ヘビークリーム様の感触であり、100mIlの
暉下は非常に容易であった。The sterilized emulsion was rapidly cooled to around 15°C, stored in a refrigerator day and night, and then placed in a sterile nitrogen-substituted stoppered flask and stored in a constant temperature bath at 37°C. This emulsion was completely dispersed in water, and the particle size of the emulsion was 3 to 10 μm. The viscosity measured with a B-type rotational viscometer (Tokyo Keiki Seisakusho! I) was 220c at 80°C.
P, 380 cP at 37°C and 730 cP at 15°C. After 1 month in the constant temperature bath, no putrefaction or oil layer separation was observed in the emulsion, but the viscosity at 37°C increased to 640 cP. When the emulsion was orally ingested after one month, it felt somewhat viscous and felt like heavy cream, and it was very easy to swallow 100 ml.
実施例3
20Qのステンレスビーカーに80℃以上の熱水804
0部を計量し、スリーワンモーターで回転数240rp
+mで攪拌しながらポロポロと崩れやすい乾いた粘土状
のE −PC−70(前出)の4000部を少量ずつ添
加し、溶液全体が弱い均一のゲル状溶液となり黄色い固
形分がなくなるまで攪拌を続けた。ゲル状の予備乳化液
に80℃以上に加熱した精製大豆油4000部を少量ず
つ添加し、攪拌速度を最高速にして半透明溶液から乳白
色溶液となるまで攪拌を続行した。この乳化液にカゼイ
ンナトリウム塩40部を少量ずつ添加し、完全に溶解す
るまで攪拌した。Example 3 Hot water 804 at 80°C or higher in a 20Q stainless steel beaker
Weigh 0 parts and rotate at 240 rpm with a three-one motor.
Add 4,000 parts of E-PC-70 (described above), which is a dry clay-like material that crumbles easily, little by little while stirring at +m, and continue stirring until the entire solution becomes a weak, homogeneous gel-like solution and no yellow solid content is present. continued. 4,000 parts of refined soybean oil heated to 80° C. or higher was added little by little to the gel-like preliminary emulsion, and stirring was continued at the highest stirring speed until the solution changed from a translucent solution to a milky white solution. 40 parts of caseinate sodium salt was added little by little to this emulsion and stirred until completely dissolved.
この乳化液を二段式ホモゲナイザー(前出)で、1段目
50kg/a#、2段目150kg/ dで精乳化した
後、オートクレーブに入れ温度110℃、圧力2kg/
jで30分滅菌し乳剤を得た。滅菌乳剤を15℃付近ま
で急冷し、−昼夜冷蔵庫に保存後、滅菌窒素置換の共栓
フラスコに入れ37℃の恒温槽に保存した。この乳剤は
水に完全分散し、エマルジョンの粒子径は2〜8μ−で
あった、粘度は80℃で360cP、37℃で520c
P、15℃で860cPであった。恒温槽中で1力月後
の乳剤は腐敗や油層分離は認められなかったが、37℃
における粘度が900cPに上昇した。1ヵ月後の乳剤
の経口摂取は粘性を少し感じる程度で。This emulsion was emulsified using a two-stage homogenizer (described above) at a rate of 50 kg/a# in the first stage and 150 kg/d in the second stage, and then placed in an autoclave at a temperature of 110°C and a pressure of 2 kg/d.
The emulsion was sterilized for 30 minutes at J. The sterilized emulsion was rapidly cooled to around 15°C, stored in a refrigerator day and night, and then placed in a sterile nitrogen-substituted stoppered flask and stored in a constant temperature bath at 37°C. This emulsion was completely dispersed in water, the particle size of the emulsion was 2 to 8 μ-, and the viscosity was 360 cP at 80°C and 520 cP at 37°C.
P, 860 cP at 15°C. No rotting or oil layer separation was observed in the emulsion after one month in the constant temperature bath, but at 37°C.
The viscosity at was increased to 900 cP. After one month, the emulsion was taken orally and only felt a little viscous.
茹卵様の臭いを持ち、コーヒークリーム様の感触であり
、100mQの幌上は非常に容易であった6実施例4
20Qのステンレスビーカーに80℃以上の熱水950
0部を計量し、スリーワンモーターで回転数24Orp
mで攪拌しながら細かく剪断した5−PC−70(前出
) 4000部を少量ずつ添加し、全体が均一の網状態
となり固形分がなくなるまで続けた。糊状の予備乳化液
に80℃以上に加熱した精製サフラワー油4000部を
少量ずつ添加し、攪拌速度を最高速にして半透明溶液か
ら乳白色溶液となるまで攪拌を続行した。この乳化液に
アルブミン20部を少量ずつ添加し、完全に溶解するま
で攪拌した。この乳化液を二段式ホモゲナイザー(前出
)で、1段目50kg/d、2段目150kg/−で精
乳化した後、オートクレーブに入れ温度110℃、圧力
2kg/aJで30分滅菌し乳剤を得た。滅菌精乳化液
を15℃付近まで急冷して一昼夜冷蔵庫に保存後、滅菌
窒素置換の共栓フラスコに入れ37℃の恒温槽に保存し
た。この乳剤は水に完全分散し、エマルジョンの粒子径
は2〜10μmであった。粘度は80℃で200cP、
37℃で320cP、15℃で600cPであった。恒
温槽中で1力月後の乳剤は腐敗や油層分離は認められな
かったが、37℃における粘度が700cPに上昇した
。1力月後の乳剤の経口摂取はわずかに粘性を感じる程
度で。It had a boiled egg-like odor and a coffee cream-like feel, and it was very easy to pour 100 mQ of hot water into a 20 Q stainless steel beaker at 950 °C or higher.
Weigh 0 parts and rotate at 24 Orp using a three-one motor.
4000 parts of finely sheared 5-PC-70 (mentioned above) was added little by little while stirring at m, and the process was continued until the whole became a uniform mesh and no solid content was left. 4,000 parts of purified safflower oil heated to 80° C. or higher was added little by little to the paste-like preliminary emulsion, and stirring was continued at the highest stirring speed until the solution changed from a translucent solution to a milky white solution. 20 parts of albumin was added little by little to this emulsion and stirred until completely dissolved. This emulsion was emulsified using a two-stage homogenizer (described above) at a rate of 50 kg/d in the first stage and 150 kg/d in the second stage, and then placed in an autoclave and sterilized at a temperature of 110°C and a pressure of 2 kg/aJ for 30 minutes to form an emulsion. I got it. The sterilized emulsion was rapidly cooled to around 15°C and stored in a refrigerator overnight, then placed in a sterile nitrogen-substituted stoppered flask and stored in a constant temperature bath at 37°C. This emulsion was completely dispersed in water, and the particle size of the emulsion was 2 to 10 μm. Viscosity is 200cP at 80℃,
It was 320 cP at 37°C and 600 cP at 15°C. After 1 month in the constant temperature bath, no putrefaction or oil layer separation was observed in the emulsion, but the viscosity at 37°C increased to 700 cP. Oral ingestion of the emulsion after 1 month feels slightly viscous.
ヘビークリーム様の感触であり、100mff1の幌上
は非常に容易であった。It had a heavy cream-like feel and was very easy to cover with 100mff1.
実施例5
20Qのステンレスビーカーに80℃以上の熱水804
0部を計量し、スリーワンモーターで回転数240rp
腸で攪拌しながらポロポロと崩れやすい乾いた粘土状の
E−PC−705000部を少量ずつ添加し、溶液全体
が弱い均一のゲル状溶液でしかも黄色い固形分がなくな
るまで攪拌を続けた。ゲル状の予備乳化液に80℃以上
に加熱した精製サフラワー油5000部を少量ずつ添加
し、攪拌速度を最高にして半透明溶液から乳白色溶液と
なるまで攪拌を続行した。この乳化液にアルブミン25
部を少量ずつ添加し、完全に溶解するまで攪拌した。こ
の乳化液を二段式ホモゲナイザー(前出)で、1段目5
0kg/d、2段目150kg/aJで精乳化した後、
オートクレーブに入れ温度110℃、圧力2kg/aJ
で30分滅菌し乳剤を得た。滅菌乳剤を15℃付近まで
急冷して一昼夜冷蔵庫に保存後、滅菌窒素置換の共栓フ
ラスコに入れ37℃の恒温槽に保存した。この乳剤は水
に完全分散し、エマルジョンの粒子径は3〜10μ醜で
あった。粘度は80℃で400cP、37℃で550c
P、15℃で940cPであった。恒温槽中で1力月後
の乳剤は腐敗や油層分離は認められなかったが、37℃
における粘度が1000cPに上昇した。1力月後の乳
剤の経口摂取は粘性をわずかに感じる程度で、コーヒー
クリーム様の感触であり、100mjlの幌上は非常に
容易であった。Example 5 Hot water 804 at 80°C or higher in a 20Q stainless steel beaker
Weigh 0 parts and rotate at 240 rpm with a three-one motor.
While stirring in the intestines, 000 parts of E-PC-705, which is a dry clay-like material that crumbles easily, was added little by little, and stirring was continued until the entire solution was a weak, homogeneous gel-like solution and no yellow solid content was present. 5,000 parts of purified safflower oil heated to 80° C. or higher was added little by little to the gel-like preliminary emulsion, and stirring was continued at the highest stirring speed until the solution changed from a translucent solution to a milky white solution. Albumin 25% is added to this emulsion.
portion was added little by little and stirred until completely dissolved. This emulsion was passed through a two-stage homogenizer (described above), and the first stage
After emulsifying at 0 kg/d and 150 kg/aJ in the second stage,
Place in an autoclave at a temperature of 110℃ and a pressure of 2kg/aJ.
The mixture was sterilized for 30 minutes to obtain an emulsion. The sterilized emulsion was rapidly cooled to around 15°C and stored in a refrigerator overnight, then placed in a sterile nitrogen-substituted stoppered flask and stored in a constant temperature bath at 37°C. This emulsion was completely dispersed in water, and the particle size of the emulsion was 3 to 10 microns. Viscosity is 400cP at 80℃ and 550c at 37℃
P, 940 cP at 15°C. No rotting or oil layer separation was observed in the emulsion after one month in the constant temperature bath, but at 37°C.
The viscosity at was increased to 1000 cP. When the emulsion was orally ingested after one month, the emulsion felt slightly viscous and had a coffee cream-like texture, and it was very easy to pour over 100 mjl.
比較例l
5−PC−24、[−PC−70、S −PC−70を
用い、オートホモミキサー(前出)を乳化装置とし、回
転数tooo。Comparative Example 1 Using 5-PC-24, [-PC-70, and S-PC-70, the autohomogen mixer (described above) was used as an emulsifying device, and the rotation speed was too high.
rpm、温度80℃で30分間の機械的乳化を行い、リ
ン脂質含量がそれぞれ5%、10%、12%、15%。Mechanical emulsification was performed at rpm and temperature of 80°C for 30 minutes, and the phospholipid content was 5%, 10%, 12%, and 15%, respectively.
17%の水性予備乳化液を得た。得られた予備乳化液の
粘度を第2表に示す。A 17% aqueous preemulsion was obtained. The viscosity of the obtained preliminary emulsion is shown in Table 2.
第 2 表 粘度(c
P)注 −は測定不能を示す。Table 2 Viscosity (c
P) Note - indicates not measurable.
いずれも均一な乳化液が得られるが、10%以上から著
しい粘度上昇を示す、この粘度上昇の傾向は、pc含量
の低いS −PC=24がE −PC−70、S −P
C−70より高濃度側に移行する。A homogeneous emulsion can be obtained in both cases, but the viscosity increases significantly from 10% or more.
Shifts to a higher concentration side than C-70.
比較例2
比較例1のNa2.&3の予備乳化液に、80℃にした
リン脂質と同量の大豆油を加え、ホモゲナイザ−(前出
)を用いて精乳化し、リン脂質含量5%、10%、12
%、15%、17%の乳化液を得た。得られた乳化液の
粘度を第3表に示す。Comparative Example 2 Na2. Add the same amount of soybean oil as the phospholipids heated to 80°C to the pre-emulsified liquid of &3, and emulsify using a homogenizer (described above) to obtain phospholipid contents of 5%, 10%, and 12%.
%, 15%, and 17% emulsions were obtained. The viscosity of the obtained emulsion is shown in Table 3.
第 3 表 粘度(cP)
比較例1の結果に比べ粘度は著しく低下し、15℃にお
ける粘度も低いが、1週間で油層分離が認められた。Table 3 Viscosity (cP)
The viscosity was significantly lower than the results of Comparative Example 1, and the viscosity at 15°C was also low, but separation of the oil layer was observed in one week.
Claims (5)
ジルコリンを20重量%以上含む精製リン脂質を得、こ
の精製リン脂質の10〜50重量%水性分散液に、前記
精製リン脂質に対して20〜100重量%の油脂および
0.1〜40重量%の蛋白質を添加混合し、均質化する
ことを特徴とするリン脂質乳剤の製造方法。(1) Neutral lipids are removed from natural lecithin to obtain a purified phospholipid containing 20% by weight or more of phosphatidylcholine, and a 10 to 50% by weight aqueous dispersion of this purified phospholipid is added to A method for producing a phospholipid emulsion, which comprises adding and mixing 100% by weight of oil and fat and 0.1 to 40% by weight of protein and homogenizing the mixture.
分散したものである特許請求の範囲第1項記載の方法。(2) The method according to claim 1, wherein the aqueous dispersion is a dispersion of purified phospholipids in hot water of 80° C. or higher.
第2項記載の方法。(3) The method according to claim 1 or 2, wherein the fat or oil is a liquid oil.
である特許請求の範囲第1項ないし第3項のいずれかに
記載の方法。(4) The method according to any one of claims 1 to 3, wherein the protein is casein sodium salt or albumin.
第1項ないし第4項のいずれかに記載の方法。(5) The method according to any one of claims 1 to 4, wherein the homogenization is performed under high pressure.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61063335A JPS62221629A (en) | 1986-03-20 | 1986-03-20 | Production of phospholipid emulsion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61063335A JPS62221629A (en) | 1986-03-20 | 1986-03-20 | Production of phospholipid emulsion |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS62221629A true JPS62221629A (en) | 1987-09-29 |
Family
ID=13226268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61063335A Pending JPS62221629A (en) | 1986-03-20 | 1986-03-20 | Production of phospholipid emulsion |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS62221629A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996025857A1 (en) * | 1995-02-22 | 1996-08-29 | Unilever Plc | High temperature cooking sauce |
WO2011162818A3 (en) * | 2010-06-23 | 2012-04-05 | Controlled Nanovolumes, Inc. | Lecithin carrier vesicles and methods of making the same |
JP2015509991A (en) * | 2011-12-21 | 2015-04-02 | アースクリーン コーポレイション | Aqueous dispersions and their precursors |
CN107306946A (en) * | 2017-05-10 | 2017-11-03 | 中国农业大学 | A kind of egg oil agricultural chemicals and its preparation method and application |
-
1986
- 1986-03-20 JP JP61063335A patent/JPS62221629A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996025857A1 (en) * | 1995-02-22 | 1996-08-29 | Unilever Plc | High temperature cooking sauce |
WO2011162818A3 (en) * | 2010-06-23 | 2012-04-05 | Controlled Nanovolumes, Inc. | Lecithin carrier vesicles and methods of making the same |
JP2015509991A (en) * | 2011-12-21 | 2015-04-02 | アースクリーン コーポレイション | Aqueous dispersions and their precursors |
CN107306946A (en) * | 2017-05-10 | 2017-11-03 | 中国农业大学 | A kind of egg oil agricultural chemicals and its preparation method and application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5997904A (en) | Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof | |
US6528067B1 (en) | Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof | |
EP0127677B1 (en) | Readily-absorpable fatty acid emulsions | |
JPS60199833A (en) | Manufacturing method of W/O/W type composite emulsion for pharmaceuticals, cosmetics, etc. | |
JPH0231834A (en) | Emulsion product and production thereof | |
JPS5924132B2 (en) | Manufacturing method for nutritional supplement emulsion | |
JPS63185350A (en) | Emulsification of fats of oils in aqueous phase consisting essentially of soy sauce | |
JPH04500301A (en) | Emulsion for water-in-oil emulsion | |
JPH0747544B2 (en) | O / W emulsion nutritional composition | |
JPH0356777B2 (en) | ||
JPS6344843A (en) | O/w/o-type emulsified oil and fat composition | |
JPS62221629A (en) | Production of phospholipid emulsion | |
JPS58162517A (en) | Fat emulsion containing fat-soluble vitamins | |
JP3132085B2 (en) | Fat emulsion | |
JPH06254378A (en) | Chemical agent for making water-soluble compound soluble in oil and production thereof | |
JPS6344842A (en) | O/w/o-type emulsified oil and fat composition | |
JPH01143826A (en) | Fine grain fat emulsion | |
JP3278427B2 (en) | Method for producing capsules | |
CN103704849B (en) | Energy bar antioxidant and preparation method thereof and the energy bar containing this antioxidant | |
WO2020203808A1 (en) | Novel method for producing lecithin organogel | |
JPH07102107B2 (en) | Liquid sterile nutritional supplement | |
JPS60237017A (en) | fat infusion | |
JPH06271420A (en) | Water absorption improver for cosmetics or external preparations for skin | |
KR20030063019A (en) | Emulsive compositions comprising high unsaturated fatty acids and their preparations for micro liquid capsules | |
JPS5933016B2 (en) | Water-in-oil-in-polyhydric alcohol emulsion composition |